PSMA PET | Hear more about a Prostate Cancer Patient’s Journey!

PET/CT is refining the understanding of prostate cancer and increasing confidence in the initial diagnosis

The 68Ga generator manufacturers have been strategically planning for the incremental 68Ga demand.

Theranostics supports the diagnosis and management of cancer patients.

Developing Cancer Detection and Treatment with Molecularly Targeted Radiation (MTR)

An 82-year-old man presented with rising PSA of 21 ng/ml in July 2015.

68 Ga PSMA-11 PET/CT is more likely to change the course of treatment than conventional imaging.

A 69-year-old man presented with a persistent rising PSA.

A 70-year-old man presented with persistent rising PSA.
© Anderson Publishing, Ltd. 2023 All rights reserved. Reproduction in whole or part without express written permission Is strictly prohibited.